SEARCH

SEARCH BY CITATION

References

  • Aicher A, Zeiher AM & Dimmeler S. (2005) Mobilizing endothelial progenitor cells. Hypertension 45, 321325.
  • Augustin HG, Koh GY, Thurston G & Alitalo K. (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10, 165177.
  • Aversa A, Francomano D, Bruzziches R, Pili M, Natali M, Spera G et al. (2011) The application of digital pulse amplitude tonometry to the diagnostic investigation of endothelial dysfunction in men with erectile dysfunction. Andrologia 43, 915.
  • Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P et al. (2010) Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. Circulation 121, 14391446.
  • Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J et al. (2005) Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertension. J Hypertens 23, 233246.
  • Dong JY, Zhang YH & Qin LQ. (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58, 13781385.
  • Elesber AA, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G et al. (2006) Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 27, 824831.
  • Esposito K, Giugliano F, Martedì E, Feola G, Marfella R, D'Armiento M et al. (2005) High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 28, 12011203.
  • Gates PE, Boucher ML, Silver AE, Monahan KD & Seals DR. (2007) Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J Appl Physiol 102, 6371.
  • Gealekman O, Guseva N, Hartigan C, Apotheker S, Gorgoglione M, Gurav K et al. (2011) Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 123, 186194.
  • Grundy G. (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92, 399404.
  • Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM et al. (2008) Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham heart study. Circulation 117, 24672474.
  • Imhof BA & Aurrand-Lions M. (2006) Angiogenesis and inflammation face off. Nat Med 12, 171172.
  • Ioakeimidis N, Vlachopoulos C, Rokkas K, Aggelis A, Terentes-Printzios D, Samentzas A et al. (2011) Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction. Eur Urol 59, 948955.
  • Iribarren C, Phelps BH, Darbinian JA, McCluskey ER, Quesenberry CP, Hytopoulos E et al. (2011) Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC Cardiovasc Disord 14, 1131.
  • Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, Feskens EJ et al. (2011) The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study. Eur J Clin Invest 41, 167175.
  • Jin HR, Kim WJ, Song JS, Piao S, Choi MJ, Tumurbaatar M et al. (2011) Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse. Diabetes 60, 969980.
  • Kaess BM, Pedley A, Massaro JM, Larson MG, Corsini E, Hoffmann U et al. (2012) Relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham heart study. J Clin Endocrinol Metab 97, 987994.
  • Kendirci M, Trost L, Sikka SC & Hellstrom WJ. (2007) The effect of vascular risk factors on penile vascular status in men with erectile dysfunction. J Urol 178, 25162520.
  • La Vignera S, Condorelli R, Vicari E, D'Agata R & Calogero AE. (2011) Arterial erectile dysfunction: reliability of new markers of endothelial dysfunction. J Endocrinol Invest 34, e314e320.
  • Lee RK, Chughtai B, Te AE & Kaplan SA. (2012) Sexual function in men with metabolic syndrome. Urol Clin North Am 39, 5362.
  • Lim HS, Lip GY & Blann AD. (2005) Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 180, 113118.
  • McKinlay J. (2000) The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 12(Suppl 4), S6S11.
  • Montorsi P, Montorsi F & Schulman C. (2003) Is erectile dysfunction the tip of the iceberg of a systemic vascular disorder? Eur Urol 22, 352354.
  • Nadar SK, Blann A, Beevers DG & Lip GY. (2005) Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 258, 336343.
  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106, 31433421.
  • Nykänen AI, Krebs R, Saaristo A, Turunen P, Alitalo K, Ylä-Herttuala S et al. (2003) Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107, 13081314.
  • Ohno Y, Hashiguchi T, Maenosono R, Yamashita H, Taira Y, Minowa K et al. (2010) The diagnostic value of endothelial function as a potential sensor of fatigue in health. Vasc Health Risk Manag 6, 135144.
  • Patvardhan EA, Heffernan KS, Ruan JM, Soffler MI, Karas RH & Kuvin JT. (2010) Assessment of vascular endothelial function with peripheral arterial tonometry: information at your fingertips? Cardiol Rev 18, 2028.
  • Pohjantähti-Maaroos H, Palomäki A & Hartikainen J. (2011) Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis. BMC Cardiovasc Disord 27, 1136.
  • Rosen RC, Cappelleri JC, Smith MD, Lipsky J & Peña BM. (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11, 319326.
  • Ryan JG & Gajraj J. (2012) Erectile dysfunction and its association with metabolic syndrome and endothelial function among patients with type 2 diabetes mellitus. J Diabetes Complications 26, 141147.
  • Silha JV, Krsek M, Sucharda P & Murphy LJ. (2005) Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 29, 13081314.
  • Tamler R & Bar-Chama N. (2008) Assessment of endothelial function in the patient with erectile dysfunction: an opportunity for the urologist. Int J Impot Res 20, 370377.
  • Tomada N, Tomada I, Cruz F, Vendeira P & Neves D. (2010) Characterization of VEGF and angiopoietins expression in human corpus cavernosum during aging. J Sex Med 7(4 Pt 1), 14101418.
  • Tomada N, Tomada I, Botelho F, Cruz F & Vendeira P. (2011) Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. J Sex Med 8, 831839.
  • Trocha M, Szuba A, Merwid-Lad A & Sozański T. (2010) Effect of selected drugs on plasma asymmetric dimethylarginine (ADMA) levels. Pharmazie 65, 562571.
  • Tuo QH, Zeng H, Stinnett A, Yu H, Aschner JL, Liao DF et al. (2008) Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 294, H2547H2557.
  • Vaudo G, Marchesi S, Siepi D, Brozzetti M, Mannarino MR, Pirro M et al. (2007) Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Metabolism 56, 541546.
  • Vermeulen A, Verdonck L & Kaufman JM. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84, 36663672.
  • Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ et al. (2009) ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res 21, 18.
  • Wierzbicki AS, Solomon H, Lumb PJ, Lyttle K, Lambert-Hammill M & Jackson G. (2006) Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction. Atherosclerosis 185, 421425.
  • Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM et al. (2008) FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodelling, and functions in adipose tissue. PNAS 105, 1016710172.